Drugs / Toremifine
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02291913 Background | Dec 2014 → Jan 2019 | breast cancer | SCRI Development Innovations, LLC | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toremifine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02291913 ↗ |